Published in Am J Med on September 01, 1966
Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest (1971) 1.76
Properties of highly purified human properdin. J Immunol (1968) 3.96
Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum (1977) 3.51
Time-motion study of practicing pediatricians. Pediatrics (1966) 3.32
Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet (1966) 3.27
Immune response after splenectomy. Lancet (1978) 2.31
Significance of bacterial variants in urine of patients with chronic bacteriuria. J Clin Invest (1965) 2.18
Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis (1973) 2.11
Hepatic involvement in juvenile rheumatoid arthritis. J Pediatr (1970) 2.05
Percutaneous CT biopsy of chest lesions: an in vitro analysis of the effect of partial volume averaging on needle positioning. AJR Am J Roentgenol (1993) 2.04
Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr (1982) 2.03
Telephone assessment of illness by practicing pediatricians. J Pediatr (1976) 1.93
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91
Immunoglobulin content of intestinal mucosal plasma-cells in ataxia telangiectasia. Lancet (1968) 1.85
Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium. J Infect Dis (1971) 1.82
Anatomy of the minor fissure: evaluation with thin-section CT. Radiology (1989) 1.80
Influence of serum and calcium on the bactericidal activity of gentamicin and carbenicillin on Pseudomonas aeruginosa. Appl Microbiol (1972) 1.79
Observational evidence for an active surface reservoir of solid carbon dioxide on Mars. Science (2001) 1.78
Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest (1971) 1.76
The primary immunodeficiencies (1). N Engl J Med (1984) 1.74
Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas. Antimicrob Agents Chemother (1972) 1.67
The primary immunodeficiencies. N Engl J Med (1995) 1.65
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Web-based digital radiology teaching file: facilitating case input at time of interpretation. AJR Am J Roentgenol (1998) 1.63
Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr (1985) 1.61
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55
Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol (1966) 1.51
Dissociation between results of in vitro and in vivo antibiotic susceptibility tests for some strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 1.51
Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism. J Clin Invest (1986) 1.49
Neonatal imitation of tongue protrusion and mouth opening: methodological aspects and evidence of early individual differences. Scand J Psychol (1989) 1.48
Septic pulmonary embolism complicating a central venous catheter. Chest (1990) 1.47
Juvenile rheumatoid arthritis: a review. Pediatrics (1972) 1.46
Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency. J Pediatr (1974) 1.46
The primary immunodeficiencies. (2). N Engl J Med (1984) 1.43
Isolation and characterization of the structural gene for secreted acid phosphatase from Schizosaccharomyces pombe. J Biol Chem (1986) 1.43
Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa. Antimicrob Agents Chemother (1975) 1.41
Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med (1979) 1.41
Needle-tip repositioning during computed-tomography-guided transthoracic needle aspiration biopsy of small deep pulmonary lesions: minor adjustments make a big difference. J Thorac Imaging (1996) 1.40
Hypergammaglobulinaemia, antibody deficiency, autoimmune haemolytic anaemia, and nephritis in an infant with a familial lymphopenic immune defect. Lancet (1966) 1.38
Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol (1998) 1.34
Parent reaction to the concept of pediatric assistants. Pediatrics (1969) 1.34
Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases. Lancet (1986) 1.31
Classification of primary immunodeficiencies. N Engl J Med (1973) 1.28
Relationships among xylem transport, biomechanics and storage in stems and roots of nine Rhamnaceae species of the California chaparral. New Phytol (2007) 1.26
LiF:Mg,Ti TLD response as a function of photon energy for moderately filtered x-ray spectra in the range of 20-250 kVp relative to 60Co. Med Phys (2008) 1.26
Paradoxical synergism and antagonism between serum and the antibacterial activity of colistin. J Infect Dis (1971) 1.23
Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy. J Infect Dis (1971) 1.21
Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM. J Biol Chem (1998) 1.21
Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs. Arch Ophthalmol (1977) 1.19
Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Respir J (2008) 1.17
Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status. J Clin Oncol (2002) 1.17
Adenosine-deaminase deficiency and severe combined immunodeficiency syndrome. Lancet (1973) 1.16
The role of complement in the induction of antibody responses. Clin Exp Immunol (1983) 1.16
The recognition and classification of immunodeficiency diseases with bacteriophage phiChi 174. Birth Defects Orig Artic Ser (1975) 1.15
Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N Engl J Med (1981) 1.13
Adenosine 5'-phosphosulfate sulfotransferase and adenosine 5'-phosphosulfate reductase are identical enzymes. J Biol Chem (2000) 1.11
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med (1984) 1.10
Autoimmunity in the relatives of patients with immunodeficiency diseases. Clin Exp Immunol (1977) 1.10
The role of penicillin-induced bacterial variants in experimental pyelonephritis. J Exp Med (1967) 1.10
Juvenile rheumatoid arthritis persisting inot adulthood. Am J Med (1968) 1.10
Bacterial L-forms in relapsing urinary-tract infection. Lancet (1967) 1.08
Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease. Ann Intern Med (1972) 1.08
Defective antibody response to bacteriophage phichi 174 in Down syndrome. J Pediatr (1975) 1.08
Combined immunodeficiency and reticuloendotheliosis with eosinophilia. J Pediatr (1974) 1.08
Perinatal infection with human immunodeficiency virus. Specific antibody responses by the neonate. N Engl J Med (1987) 1.07
The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. J Lab Clin Med (1988) 1.06
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J (1998) 1.05
Plant adenosine 5'-phosphosulfate reductase is a novel iron-sulfur protein. J Biol Chem (2001) 1.05
Topical tobramycin therapy of experimental Pseudomonas keratitis: an evaluation of some factors that potentially enhance efficacy. Arch Ophthalmol (1978) 1.05
Antibody studies in hypogammaglobulinemia. J Clin Invest (1966) 1.04
Histocompatibility antigens in childhood-onset arthritis. J Pediatr (1976) 1.04
Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum (1989) 1.03
Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect Immun (1979) 1.03
Relative antagonism in vitro of calcium in serum to the bactericidal activities of gentamicin and tobramycin on Pseudomonas aeruginosa. Chemotherapy (1973) 1.02
Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy. Arch Ophthalmol (1978) 1.01
Induction of T-lymphocyte differentiation by thymic epithelial cell monolayers. Clin Immunol Immunopathol (1978) 1.01
Experimental keratitis due to Pseudomonas aeruginosa: model for evaluation of antimicrobial drugs. Antimicrob Agents Chemother (1975) 1.01
Intravenous immunoglobulin: a review. Immunodefic Rev (1989) 1.01
Lysozyme and serum bactericidal action. Nature (1966) 1.01
Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Biochemistry (1999) 0.99
Pulmonary artery sarcoma: evaluation using Gd-DTPA. J Comput Assist Tomogr (1990) 0.99